Sanofi www.sanofi.com announced results from a phase 3 trial assessing Dupixent (dupilumab) in patients 12 years and older with eosinophilic esophagitis (EoE). The trial met its…
Do the mRNA-based vaccines for COVID-19 pose any threat to highly allergic individuals or those with Mast Cell Disorder? Apparently, Dr. Anthony Fauci and the National…
Penicillin, a life-saving medicine, is the most common cause of drug allergy, with clinical manifestations ranging from temporary skin reactions to life-threatening systemic syndromes. Thus…
Stacie M. Jones, M.D., is Professor and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital…
Novartis is sponsoring a global clinical trial led by an investigator with Charite-University Medicine, Berlin Germany—along with over a hundred other sites they are in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
